[Retracted] HDAC3 Inhibition Alleviates High‐Glucose‐Induced Retinal Ganglion Cell Death through Inhibiting Inflammasome Activation

Dongyi Yu, Qing Tang, Lili Liu, Dawei He, Libo Wang, Xin Zhou

Open source

DOI
10.1155/2022/4164824
Published
2022-01
Container
BioMed Research International
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/4164824,
  title = {[Retracted] HDAC3 Inhibition Alleviates High‐Glucose‐Induced Retinal Ganglion Cell Death through Inhibiting Inflammasome Activation},
  author = {Dongyi Yu and Qing Tang and Lili Liu and Dawei He and Libo Wang and Xin Zhou},
  year = {2022},
  journal = {BioMed Research International},
  doi = {10.1155/2022/4164824},
  url = {https://doi.org/10.1155/2022/4164824}
}

RIS

TY  - JOUR
TI  - [Retracted] HDAC3 Inhibition Alleviates High‐Glucose‐Induced Retinal Ganglion Cell Death through Inhibiting Inflammasome Activation
AU  - Dongyi Yu
AU  - Qing Tang
AU  - Lili Liu
AU  - Dawei He
AU  - Libo Wang
AU  - Xin Zhou
PY  - 2022
JO  - BioMed Research International
DO  - 10.1155/2022/4164824
UR  - https://doi.org/10.1155/2022/4164824
ER  - 

APA

Yu, D., Tang, Q., Liu, L., He, D., Wang, L., & Zhou, X. (2022). [Retracted] HDAC3 Inhibition Alleviates High‐Glucose‐Induced Retinal Ganglion Cell Death through Inhibiting Inflammasome Activation. BioMed Research International. https://doi.org/10.1155/2022/4164824

Source records